Literature DB >> 21987543

Large kindred evaluation of mitofusin 2 novel mutation, extremes of neurologic presentations, and preserved nerve mitochondria.

Christopher J Klein1, Grace W Kimmel, Sean J Pittock, JaNean E Engelstad, Julie M Cunningham, Yanhong Wu, Peter J Dyck.   

Abstract

BACKGROUND: Mitofusin 2 (MFN2) is a mitochondrial membrane protein mediating mitochondrial fusion and function. Mutated MFN2 is responsible for Charcot-Marie-Tooth type 2A2. In small kindreds, specific MFN2 mutations have been reported to associate with severity of axonal neuropathy, optic atrophy, and involvement of the central nervous system. The results of the nerve biopsy specimens suggested that the mitochondria are structurally abnormal in patients with MFN2 mutations.
OBJECTIVE: To study a newly identified MFN2 mutation, Leu146Phe, and the associated phenotypes in a large kindred. PATIENTS: An American kindred of Northern European and Cherokee American Indian descent.
RESULTS: Genetic analysis revealed a novel GTPase domain MFN2 mutation Leu146Phe that associated with clinical status of 15 studied persons (10 affected and 5 unaffected) and not found in 800 control persons. Clinical manifestations were markedly different. In 1 affected person, optic atrophy and brain magnetic resonance imaging abnormalities led to multiple sclerosis diagnosis and interferon β-1a treatment when neuropathy was initially unrecognized. Age of onset ranged from 1 to 45 years. In some affected family members, severe and rapid-onset motor sensory neuropathy led to early loss of ambulation, whereas other family members experienced minimal neuropathic sensory symptoms. Despite histologically significant loss of nerve fibers, the mitochondria were not distinguishable from diseased sural nerve biopsy specimens and healthy controls.
CONCLUSIONS: Novel MFN2 mutation Leu146Phe causes Charcot-Marie-Tooth type 2A2. Intrafamilial clinical phenotype variability is emphasized and has important implications in genetic counseling. The clinical phenotype may mimic multiple sclerosis when optic atrophy and the characteristic brain lesions of MFN2 on magnetic resonance imaging are present and neuropathy is mild or unrecognized. The predicted molecular pathogenesis may occur without evident histological abnormalities of mitochondria in nerve.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21987543      PMCID: PMC3543870          DOI: 10.1001/archneurol.2011.225

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  19 in total

1.  Severe CMT type 2 with fatal encephalopathy associated with a novel MFN2 splicing mutation.

Authors:  F Boaretto; A Vettori; A Casarin; G Vazza; M Muglia; M G Rossetto; T Cavallaro; N Rizzuto; V Carelli; L Salviati; M L Mostacciuolo; A Martinuzzi
Journal:  Neurology       Date:  2010-06-08       Impact factor: 9.910

2.  Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations.

Authors:  K W Chung; S B Kim; K D Park; K G Choi; J H Lee; H W Eun; J S Suh; J H Hwang; W K Kim; B C Seo; S H Kim; I H Son; S M Kim; I N Sunwoo; B O Choi
Journal:  Brain       Date:  2006-07-10       Impact factor: 13.501

3.  Genotype-phenotype correlations in Charcot-Marie-Tooth disease type 2 caused by mitofusin 2 mutations.

Authors:  Judith Calvo; Benoît Funalot; Robert A Ouvrier; Leila Lazaro; Annick Toutain; Philippe De Mas; Pierre Bouche; Brigitte Gilbert-Dussardier; Marie-Christine Arne-Bes; Jean-Pierre Carrière; Hubert Journel; Marie-Christine Minot-Myhie; Claire Guillou; Karima Ghorab; Laurent Magy; Franck Sturtz; Jean-Michel Vallat; Corinne Magdelaine
Journal:  Arch Neurol       Date:  2009-12

4.  Histopathological findings in hereditary motor and sensory neuropathy of axonal type with onset in early childhood associated with mitofusin 2 mutations.

Authors:  Jean-Michel Vallat; Robert A Ouvrier; John D Pollard; Corinne Magdelaine; Danqing Zhu; Garth A Nicholson; Simon Grew; Monique M Ryan; Benoît Funalot
Journal:  J Neuropathol Exp Neurol       Date:  2008-11       Impact factor: 3.685

5.  Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations.

Authors:  G A Nicholson; C Magdelaine; D Zhu; S Grew; M M Ryan; F Sturtz; J-M Vallat; R A Ouvrier
Journal:  Neurology       Date:  2008-05-06       Impact factor: 9.910

6.  Mitofusin 2 tethers endoplasmic reticulum to mitochondria.

Authors:  Olga Martins de Brito; Luca Scorrano
Journal:  Nature       Date:  2008-12-04       Impact factor: 49.962

7.  Cerebral involvement in axonal Charcot-Marie-Tooth neuropathy caused by mitofusin2 mutations.

Authors:  Knut Brockmann; Steffi Dreha-Kulaczewski; Peter Dechent; Carsten Bönnemann; Gunther Helms; Marten Kyllerman; Wolfgang Brück; Jens Frahm; Kathrin Huehne; Jutta Gärtner; Bernd Rautenstrauss
Journal:  J Neurol       Date:  2008-04-21       Impact factor: 4.849

Review 8.  Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A.

Authors:  Romain Cartoni; Jean-Claude Martinou
Journal:  Exp Neurol       Date:  2009-05-08       Impact factor: 5.330

9.  Mitochondrial coupling defect in Charcot-Marie-Tooth type 2A disease.

Authors:  Dominique Loiseau; Arnaud Chevrollier; Christophe Verny; Virginie Guillet; Naïg Gueguen; Marie-Anne Pou de Crescenzo; Marc Ferré; Marie-Claire Malinge; Agnès Guichet; Guillaume Nicolas; Patrizia Amati-Bonneau; Yves Malthièry; Dominique Bonneau; Pascal Reynier
Journal:  Ann Neurol       Date:  2007-04       Impact factor: 10.422

10.  Mutated mitofusin 2 presents with intrafamilial variability and brain mitochondrial dysfunction.

Authors:  R Del Bo; M Moggio; M Rango; S Bonato; M G D'Angelo; S Ghezzi; G Airoldi; M T Bassi; M Guglieri; L Napoli; C Lamperti; S Corti; A Federico; N Bresolin; G P Comi
Journal:  Neurology       Date:  2008-10-22       Impact factor: 9.910

View more
  9 in total

Review 1.  Inherited neuropathies: clinical overview and update.

Authors:  Christopher J Klein; Xiaohui Duan; Michael E Shy
Journal:  Muscle Nerve       Date:  2013-06-26       Impact factor: 3.217

2.  Restoring mitofusin balance prevents axonal degeneration in a Charcot-Marie-Tooth type 2A model.

Authors:  Yueqin Zhou; Sharon Carmona; A K M G Muhammad; Shaughn Bell; Jesse Landeros; Michael Vazquez; Ritchie Ho; Antonietta Franco; Bin Lu; Gerald W Dorn; Shaomei Wang; Cathleen M Lutz; Robert H Baloh
Journal:  J Clin Invest       Date:  2019-03-18       Impact factor: 14.808

Review 3.  Mitochondrial Membrane Dynamics and Inherited Optic Neuropathies.

Authors:  Eleni Bagli; Anastasia K Zikou; Niki Agnantis; Georgios Kitsos
Journal:  In Vivo       Date:  2017 Jul-Aug       Impact factor: 2.155

4.  A novel MFN2 mutation causes variable clinical severity in a multi-generational CMT2 family.

Authors:  Lois Dankwa; Jessica Richardson; William W Motley; Mena Scavina; Steve Courel; Tanya Bardakjian; Stephan Züchner; Steven S Scherer
Journal:  Neuromuscul Disord       Date:  2018-12-21       Impact factor: 4.296

Review 5.  Analysis of mitochondrial structure and function in the Drosophila larval musculature.

Authors:  Zong-Heng Wang; Cheryl Clark; Erika R Geisbrecht
Journal:  Mitochondrion       Date:  2015-12-01       Impact factor: 4.160

6.  Mice Hemizygous for a Pathogenic Mitofusin-2 Allele Exhibit Hind Limb/Foot Gait Deficits and Phenotypic Perturbations in Nerve and Muscle.

Authors:  Peter Bannerman; Travis Burns; Jie Xu; Laird Miers; David Pleasure
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

7.  Natural history of Charcot-Marie-Tooth disease type 2A: a large international multicentre study.

Authors:  Menelaos Pipis; Shawna M E Feely; James M Polke; Mariola Skorupinska; Laura Perez; Rosemary R Shy; Matilde Laura; Jasper M Morrow; Isabella Moroni; Chiara Pisciotta; Franco Taroni; Dragan Vujovic; Thomas E Lloyd; Gyula Acsadi; Sabrina W Yum; Richard A Lewis; Richard S Finkel; David N Herrmann; John W Day; Jun Li; Mario Saporta; Reza Sadjadi; David Walk; Joshua Burns; Francesco Muntoni; Sindhu Ramchandren; Rita Horvath; Nicholas E Johnson; Stephan Züchner; Davide Pareyson; Steven S Scherer; Alexander M Rossor; Michael E Shy; Mary M Reilly
Journal:  Brain       Date:  2020-12-01       Impact factor: 13.501

8.  Clinical and genetic features of a cohort of patients with MFN2-related neuropathy.

Authors:  Elena Abati; Arianna Manini; Daniele Velardo; Roberto Del Bo; Laura Napoli; Federica Rizzo; Maurizio Moggio; Nereo Bresolin; Emilia Bellone; Maria Teresa Bassi; Maria Grazia D'Angelo; Giacomo Pietro Comi; Stefania Corti
Journal:  Sci Rep       Date:  2022-04-13       Impact factor: 4.379

Review 9.  Animal Models of CMT2A: State-of-art and Therapeutic Implications.

Authors:  Roberta De Gioia; Gaia Citterio; Elena Abati; Monica Nizzardo; Nereo Bresolin; Giacomo Pietro Comi; Stefania Corti; Federica Rizzo
Journal:  Mol Neurobiol       Date:  2020-08-27       Impact factor: 5.590

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.